NCT03429465: TRY

Training Resiliency in Youth (TRY) Study

Completed NA Last updated 8 August 2018

What this trial tests

NA trial testing EVO Cognitive Remediation Game in Attention Concentration Difficulty in 46 participants. Completed in 4 June 2018.

Timeline

16 January 2018

Primary endpoint
4 June 2018

4 June 2018

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	46
Start date	16 January 2018
Primary completion	4 June 2018
Estimated completion	4 June 2018
Sites	1 location across United States

Drugs / interventions tested

• EVO Cognitive Remediation Game

Conditions studied

• Attention Concentration Difficulty — all drugs for Attention Concentration Difficulty →
• Depression — all drugs for Depression →
• Anxiety — all drugs for Anxiety →

Sponsor

University of Washington

Who can join

Eligibility, any sex, with Attention Concentration Difficulty or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to determine whether a neuroscience-inspired cognitive remediation video game (EVO) that targets the cognitive control network (CCN) will improve executive functioning (EF) and resilience to psychiatric symptoms in typically developing 6th grade students, unselected for specific psychiatric symptoms. The primary goals are to 1) determine if EVO will result in improved EF and lower internalizing (e.g., mood, anxiety) and externalizing (e.g., attention deficit/hyperactivity disorder, AD/HD) psychiatric symptoms, 2) evaluate whether the benefit experienced by youth changes depending on their level of life stress (e.g., academic or social difficulties), 3) determine if EVO will promote resilience to stress. The investigators will measure EF, symptoms, and stress using self- and parent-report questionnaires. Other secondary outcomes include information on behavior in the classroom and academic performance (i.e., grades) that we will collect via school records. The investigators hypothesize that engagement with EVO 20-minutes per day, 5-days a week across 4-weeks will improve EF, lower psychiatric symptoms, improve academic/behavioral functioning at school, and decrease maladaptive responses to stress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.